View Item 

Show simple item record

Differential Recognition of ACE Inhibitors in Xenopus Laevis Oocytes Expressing Rat PEPT1 and PEPT2
dc.contributor.authorZhu, Tongen_US
dc.contributor.authorSteel, Angelaen_US
dc.contributor.authorSmith, David E.en_US
dc.contributor.authorChen, Xing-Zhenen_US
dc.contributor.authorHediger, Matthias A.en_US
dc.date.accessioned2006-09-08T19:18:24Z
dc.date.available2006-09-08T19:18:24Z
dc.date.issued2000-05en_US
dc.identifier.citationZhu, Tong; Chen, Xing-Zhen; Steel, Angela; Hediger, Matthias A.; Smith, David E.; (2000). "Differential Recognition of ACE Inhibitors in Xenopus Laevis Oocytes Expressing Rat PEPT1 and PEPT2." Pharmaceutical Research 17(5): 526-532. <http://hdl.handle.net/2027.42/41482>en_US
dc.identifier.issn0724-8741en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41482
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10888303&dopt=citationen_US
dc.description.abstractPurpose . To examine the mechanism of inhibition of glycylsarcosine(GlySar) transport by quinapril and enalapril, and whether or notangiotensin converting enzyme (ACE) inhibitors are transported by PEPT2as well as by PEPT1.en_US
dc.format.extent509168 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherQuinaprilen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherACE Inhibitorsen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacyen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherPEPT2en_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherEnalaprilen_US
dc.subject.otherCaptoprilen_US
dc.subject.otherPEPT1en_US
dc.titleDifferential Recognition of ACE Inhibitors in Xenopus Laevis Oocytes Expressing Rat PEPT1 and PEPT2en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy and Upjohn Center for Clinical Pharmacology, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumCollege of Pharmacy and Upjohn Center for Clinical Pharmacology, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationotherMembrane Biology Program and Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115en_US
dc.contributor.affiliationotherMembrane Biology Program and Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115en_US
dc.contributor.affiliationotherMembrane Biology Program and Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115; Anti-Infectives Research, SmithKline Beecham Pharmaceuticals, 1250 S. Collegeville Road, P.O. Box 5089, Collegeville, Pennsylvania, 19426en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid10888303en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41482/1/11095_2004_Article_223193.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1007556630189en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_223193.pdf
Size:
497.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.